Literature DB >> 12869208

Comparison of Plasmodium falciparum transfection methods.

Tina S Skinner-Adams1, Paula M Lawrie, Paula L Hawthorne, Donald L Gardiner, Katharine R Trenholme.   

Abstract

The development of an electroporation based transfection method for Plasmodium falciparum has been very successful for the study of some genes but its efficiency remains very low. While alternative approaches have been documented, electroporation of infected red blood cells generally remains the method of choice for introducing DNA into P. falciparum. In this paper we compare four published transfection techniques in their ability to achieve stable transfections.

Entities:  

Mesh:

Year:  2003        PMID: 12869208      PMCID: PMC166142          DOI: 10.1186/1475-2875-2-19

Source DB:  PubMed          Journal:  Malar J        ISSN: 1475-2875            Impact factor:   2.979


Technology enabling the genetic manipulation of malaria parasites has advanced greatly in recent years. Early success with the transfection of rodent Plasmodium species [1] was followed by the achievement of transient [2] and stable transfections in Plasmodium falciparum [3-5]. Today transfection technology is instrumental in assessing numerous aspects of P. falciparum biology, including gene function [6] and protein targeting [7]. However, progress in this area is still limited by poor transfection efficiencies and by the number and type of genetic modifications that can be achieved with current vectors. New vectors that permit both positive and negative selection are becoming available and will address many of the limitations of the current vectors [8,9]. However, the length of time required to obtain a stable transfection can still be rate-limiting. Electroporation of infected red blood cells is generally the method of choice for introducing DNA into P. falciparum. Alternative approaches including the electroporation of uninfected red blood cells to allow spontaneous uptake of DNA [10] and the use of polyamidoamine dendrimers to transfer DNA across membranes [11] have been investigated in an effort to improve transfection efficiency. Each of these alternative methods have been shown to result in substantially higher levels of reporter signals than is achieved with methods of direct electroporation. However it is not known if these techniques have an improved efficiency in establishing stable transfections. Transient transfection efficiency is believed to be some fifty times higher than stable transfection, but is often of little value to investigators performing transfections experiments with P. falciparum. In order to optimize transfection efficiency and establishment of stable transfections we have compared four published transfection techniques in their ability to achieve stable transfection. These are the electroporation methods of Wu et al [2] and Fiddock et al. [12], the spontaneous uptake method of Deitsch et al [10] and the polyamidoamine dendrimer method of Mamoun et al. [11] An additional chemical transfection agent, Effectene (Qiagen) was also tested.

Materials and Methods

Parasites

P. falciparum clone 3D7, obtained from D. Walliker (University of Edinburgh, Edinburgh UK), was cultured as described [13] and cultures containing 10% ring stage parasites were used for all transfection experiment. The experimental drug WR99210 (Jacobus Pharmaceutical Company, New Jersey) was use to select for parasites containing plasmid. The growth and development of each transfection was monitored by Giemsa stained thin smears. Cultures in which drug resistant parasites could be detected before day 31 post transfection were considered to be stably transfected.

Construction of the plasmid vector pHH1-DAG and DNA preparation

The P. falciparum expression vector pHH1 [14] was used to construct a pHH1-DAG knockout plasmid for use in all experiments. In this vector, the T. gondii dhfr-ts is replaced with the human dhfr mutated to encode resistance to WR99210 [12]. The transfection construct pHH1-DAG was made using oligonucleotides 4137D-X5' (GACTCGAGGCCAACTCGAAACTTCCTGC) and 4137E-X5' (GACTCGAGCATCTTTTGCTTGCGGCCGG) to generate an 899 bp PCR product corresponding to part of a gene on the right arm of chromosome 9, (PlasmoDB identifier PFI 1735c) but missing both the 3' and 5' regions. The pHH1 vector was digested with Xho1 and Bgl1 to release the hsp86 upstream regulatory sequence, the Xho1 and Bgl1 ends were then "filled " and the 899 bp PCR product blunt end cloned into this site to create the vector pHH1-DAG. The plasmid was propagated in PMC103 cells and prepared using Qiagen Mega Prep columns. Sufficient plasmid was prepared for all experiments, pooled and stored at -70°C until required.

Transfection methods

In order to make all transfection experiments as comparable as possible, red blood cells were drawn from a single donor 2–3 hours prior to the transfection being performed. The same donor was used for all experiments. All plasmid used was from a single plasmid pool (see above). While it was not possible to carry out all transfections simultaneously, strict monitoring ensured that all transfections were maintained under the same environmental conditions.

Spontaneous Uptake of DNA from erythrocytes

The method is essentially as described [10]. Briefly, a 240 μl aliquot of erythrocytes was washed 3 times in RPMI 1640 and once in 5 mls cytomix [2]. Fifty μg of DNA was added with cytomix to give a final volume of 400 μl. The cells were transferred to a 0.2 cm cuvette, chilled on ice and electroporated using a Bio-Rad gene pulser and 0.31 kV, 960 μf. After electroporation the erythrocytes were washed once with RPMI 1640 and resuspended to a 5% haematocrit in complete culture media. A 4.5 ml aliquot of this suspension was dispensed into a 150 mm petri dish and inoculated with 0.5 mls of parasite culture. The culture was diluted with DNA loaded RBC's as required until drug pressure was applied on day 6 post transfection and maintained at 5 μm WR99210 thereafter.

Electroporation method 1

The method was essentially as described by Wu et al. [2]. Briefly, parasitized red blood cells were pelleted and resuspended in cytomix containing 150 μg DNA to give a final volume of 800 μl. Electroporations were carried out in 0.4 cm cuvettes using settings of 2.5 kV, 25 μf. Electroporated samples were immediately mixed with 30 mls complete culture media and fresh RBC's added to give a 5% haematocrit in a 150 mm petri dish. Cultures were maintained without drug pressure for 48 hours and then maintained on 5 μm WR99210 thereafter

Electroporation method 2

The method was essentially as described by Fidock and Wellems [12]. Briefly, parasitized red blood cells were pelleted and resuspended in cytomix containing 150 μg DNA to give a final volume of 800 μl. Electroporations were carried out in 0.4 cm cuvettes using settings of 0.31 kV and 960 μf. Electroporated samples were immediately mixed with 30 mls complete culture media and fresh RBCs added to give a 5% haematocrit in a 150 mm petri dish. Cultures were maintained without drug pressure for 48 hours and then maintained on 5 μm WR99210 thereafter

Chemical Transfection method 1 (Superfect)

The method is essentially as described by Mamoun et al. [11] and the manufacturer (Qiagen). 10 μ DNA was incubated with 40 μl superfect reagent for 10 mins and then mixed with 1 ml of complete culture media. This mix was then added drop wise to 240 μl packed parasitized red blood cells. Cultures were maintained for 48 hours without drug pressure and were diluted with fresh red blood cells when required.

Chemical Transfection method 2 (Effectene)

This method was carried out according to the manufacturers instructions (Qiagen), 2 μg DNA was mixed with buffer EC to a volume of 300 μl, 16 μl of enhancer was added and the mix incubated for 5 mins at room temperature. 60 μl of Effectene reagent was added to the mix and incubated for a further 10 mins before the addition of 1 ml complete culture medium. This DNA mix was then added drop wise to 240 μl packed parasitized red blood cells. After DNA addition 4.5 ml of complete media was added to the cells. Cultures were maintained for 48 hours without drug pressure and were diluted with fresh red blood cells when required.

Results and Discussion

All transfections performed using the high voltage/low capacitance method of Wu et al. [2] resulted in stable transfection (Table 1). However, only one of four transfections performed using the low voltage/high capacitance method of Fiddock et al. [12] was successful. This contrasts with previous findings [12] and may be because in previous studies the success of transfection was measured by expression of a reporter gene, whereas we only considered a transfection to be successful if continuous growth of parasites after drug selection was achieved. Differences in viability post-electroporation are not believed to be responsible for the different transfection efficiencies of these 2 protocols as no difference in parasite growth was observed. We acknowledge that other factors relating to red cells, parasites, vectors or equipment may have contributed to the observed differences, investigating these factors was beyond the scope of this study.
Table 1

In vitro efficacy of P. falciparum transfection techniques.

Method of TransfectionParasite Positive (Day)1% Parasitaemia (Day)Success Rate (%)
Spontaneous Uptake (Deitsch et al. 2001)100%
Transfection 11924
Transfection 216C
Transfection 31924
Transfection 41724
Average1824

Electroporation A (Wu et al. 1995)100%
Transfection 13036
Transfection 23037
Transfection 31720
Transfection 41619
Average2328

Electroporation B (Fiddock et al. 1997)25%
Transfection 1N/AN/A
Transfection 2N/AN/A
Transfection 31619
Transfection 4N/AN/A

SuperFect (Mamoun et al. 1999)0%
Transfection 1N/AN/A
Transfection 2N/AN/A

Effectene0%
Transfection 1N/AN/A
Transfection 2N/AN/A

N/A Not achieved C culture lost due to contamination

In vitro efficacy of P. falciparum transfection techniques. N/A Not achieved C culture lost due to contamination The spontaneous uptake method of Deitsch et al. [10] was the most successful of all the methods assessed. All four cultures transfected using this technique grew out after drug selection. This technique was labour intensive, requiring the addition of DNA loaded red blood cells for several days before drug selection. However, as fewer parasites were required, less media and other consumables were needed. The electroporation of uninfected red cells rather than the parasites themselves is likely to be an important factor in the success of this method as it has no impact on parasite viability. This technique has also been shown to be successful in achieving stable transfections with smaller amounts of DNA than the 200 μg used here making this method of transfection extremely favourable. Success with the SuperFect method has been previously repored [11] and the protocol used during this study was essentially as described, however we were unable to use either the SuperFect or Effectene reagent to generate stable transfectants. Optimization experiments with both the SuperFect and the Effectene protocols may be the key to improving transfection efficiencies with these chemical reagents, however, the very nature of these products and their method of DNA delivery suggests that they may be of limited value in this area of research.

Conclusions

Genetic manipulation of P. falciparum relies on transfection techniques which have a low level of efficiency and multiple transfections are often required before a stable transfection can be established. We have examined established and novel transfection techniques in order to determine the method most likely to result in stable transfections. Our data suggest that electroporation is the best method to deliver DNA into these parasites and that the spontaneous uptake protocol of Deitsch et al. [10] may be the most efficient of those currently in use.

Authors' contributions

TSA participated in the design of the study, performed the transfections and drafted the manuscript. KT conceived of the study and participated in its design and coordination. PL and PH, carried out plasmid preparations and tissue culture. DG designed and built the vector. All authors read and approved the final manuscript.
  14 in total

Review 1.  Malaria transfection and transfection vectors.

Authors:  Donald L Gardiner; Tina S Skinner-Adams; Tobias Spielmann; Katharine R Trenholme
Journal:  Trends Parasitol       Date:  2003-09

2.  Characterization of promoters and stable transfection by homologous and nonhomologous recombination in Plasmodium falciparum.

Authors:  B S Crabb; A F Cowman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

3.  Transformation of malaria parasites by the spontaneous uptake and expression of DNA from human erythrocytes.

Authors:  K Deitsch; C Driskill; T Wellems
Journal:  Nucleic Acids Res       Date:  2001-02-01       Impact factor: 16.971

4.  Transformation with human dihydrofolate reductase renders malaria parasites insensitive to WR99210 but does not affect the intrinsic activity of proguanil.

Authors:  D A Fidock; T E Wellems
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

5.  Inhibition of Plasmodium falciparum clag9 gene function by antisense RNA.

Authors:  D L Gardiner; D C Holt; E A Thomas; D J Kemp; K R Trenholme
Journal:  Mol Biochem Parasitol       Date:  2000-09       Impact factor: 1.759

6.  Stable transgene expression in Plasmodium falciparum.

Authors:  B S Crabb; T Triglia; J G Waterkeyn; A F Cowman
Journal:  Mol Biochem Parasitol       Date:  1997-12-01       Impact factor: 1.759

7.  Puromycin-N-acetyltransferase as a selectable marker for use in Plasmodium falciparum.

Authors:  T F de Koning-Ward; A P Waters; B S Crabb
Journal:  Mol Biochem Parasitol       Date:  2001-10       Impact factor: 1.759

8.  Human malaria parasites in continuous culture.

Authors:  W Trager; J B Jensen
Journal:  Science       Date:  1976-08-20       Impact factor: 47.728

9.  Stable transfection of malaria parasite blood stages.

Authors:  M R van Dijk; A P Waters; C J Janse
Journal:  Science       Date:  1995-06-02       Impact factor: 47.728

10.  Transfection of Plasmodium falciparum within human red blood cells.

Authors:  Y Wu; C D Sifri; H H Lei; X Z Su; T E Wellems
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-14       Impact factor: 11.205

View more
  6 in total

1.  A Fast-Track Phenotypic Characterization of Plasmodium falciparum Vaccine Antigens through Lyse-Reseal Erythrocytes Mediated Delivery (LyRED) of RNA Interference for Targeted Translational Repression.

Authors:  Malabika Chakrabarti; Swati Garg; Akshay Munjal; Sweta Karan; Soumya Pati; Lalit C Garg; Shailja Singh
Journal:  Methods Mol Biol       Date:  2022

2.  Synchronisation of Plasmodium falciparum and P. knowlesi In Vitro Cultures Using a Highly Specific Protein Kinase Inhibitor.

Authors:  Margarida Ressurreição; Robert William Moon; David Andrew Baker; Christiaan van Ooij
Journal:  Methods Mol Biol       Date:  2022

3.  Comparison of the absolute and relative efficiencies of electroporation-based transfection protocols for Plasmodium falciparum.

Authors:  Sandra Hasenkamp; Karen T Russell; Paul Horrocks
Journal:  Malar J       Date:  2012-06-21       Impact factor: 2.979

4.  Heterologous expression in Toxoplasma gondii reveals a topogenic signal anchor in a Plasmodium apicoplast protein.

Authors:  Aishwarya Narayan; Pragati Mastud; Vandana Thakur; Pradipsinh K Rathod; Asif Mohmmed; Swati Patankar
Journal:  FEBS Open Bio       Date:  2018-10-22       Impact factor: 2.693

5.  An integrated strategy for efficient vector construction and multi-gene expression in Plasmodium falciparum.

Authors:  Jeffrey C Wagner; Stephen J Goldfless; Suresh M Ganesan; Marcus C S Lee; David A Fidock; Jacquin C Niles
Journal:  Malar J       Date:  2013-10-26       Impact factor: 2.979

Review 6.  Targeting Gametocytes of the Malaria Parasite Plasmodium falciparum in a Functional Genomics Era: Next Steps.

Authors:  Jyotsna Chawla; Jenna Oberstaller; John H Adams
Journal:  Pathogens       Date:  2021-03-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.